Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × NETWORK × alectinib × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiotherapy 39 Cisplatin 33 Fluorouracil 16 Paclitaxel 14 Docetaxel 14 Carboplatin 13 Doxorubicin 12 Cyclophosphamide 11 Filgrastim 10 Etoposide 10 Capecitabine 10 Surgical Procedures, Operative 9 Methotrexate 9 Gemcitabine 9 Chemotherapy, Adjuvant 9 Oxaliplatin 8 Leucovorin 8 Vincristine 7 Peripheral Blood Stem Cell Transplantation 7 Bevacizumab 7 Radiotherapy, Conformal 6 Dexamethasone 6 Cetuximab 6 Prednisone 5 Neoadjuvant Therapy 5 Mitomycin 5 Ifosfamide 5 Fenretinide 5 Vinblastine 4 Topotecan 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03445000 2025-04-08

ALERT-lung

ETOP IBCSG Partners Foundation

Phase 2 Terminated

14 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡